Overview

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

Status:
Completed
Trial end date:
2015-08-21
Target enrollment:
Participant gender:
Summary
This is a phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy and safety of eravacycline compared with levofloxacin in participants with complicated urinary tract infections (cUTI).
Phase:
Phase 3
Details
Lead Sponsor:
Tetraphase Pharmaceuticals, Inc.
Treatments:
Levofloxacin
Ofloxacin